₹ 92.44 Cr
2.47%
BSE Healthcare TRI
INF663L01Z86
5000.0
1000.0
1000
Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, Puneet Pal
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| PGIM India Healthcare Fund - Regular Plan - IDCW Option | 10.87 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.77 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.09 |
| ASTER DM HEALTHCARE LIMITED EQ | 6.4 |
| JB Chemicals & Pharmaceuticals Limited | 6.36 |
| Nuvama Wealth Management Limited | 5.95 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.29 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.12 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 4.66 |
| Krishna Institute Of Medical Sciences Limited | 3.77 |
| NAVIN FLUORINE INTERNATIONAL LTD EQ NEW FV RS. 2/- | 3.06 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 90.18 |
| Chemicals | 3.06 |
| Financial Services | 2.55 |
| Consumer Services | 0.75 |
| Information Technology | 0.55 |
| Scheme Name | 5Y (%) |
|---|---|
| PGIM India Healthcare Fund Reg IDCW | 0.0 |